Cinqair Injection, Solution, Concentrate
Product Images NDC 59310-610

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Cinqair (NDC 59310-610). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Respiratory, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Image 1)

Figure 1 (Image 1)
A Kaplan-Meier curve displaying the probability of not experiencing an asthma exacerbation over time. The graph compares CINQAIR 3.0 mg/kg treatment to placebo across approximately 50 weeks, showing the time to first asthma exacerbation in patients with respective sample sizes noted for each group.*
FDA Label Image

Figure 2 (Image 2)

Figure 2 (Image 2)
Line graph showing the least squares mean change from baseline in FEV1 (L) over a 16-week period for two groups: placebo (N=105) and CINQAIR 3.0 mg/kg (N=103). The X-axis represents visit times at baseline, week 4, week 8, week 12, and week 16. The Y-axis shows changes in FEV1 from 0.00 to 0.50 L. CINQAIR shows a greater increase in FEV1 compared to placebo, with error bars indicating variability at each visit.*
FDA Label Image

Trade Carton Image (Image 3)

Trade Carton Image (Image 3)
CINQAIR (reslizumab) Injection 100 mg/10 mL (10 mg/mL) carton label for intravenous infusion. The label states it is sterile, single-use vial, and must be refrigerated. Manufacturer is Teva Respiratory, LLC. The label includes storage instructions, barcode, and dosage warnings.*
FDA Label Image

Sample Carton Image (Image 4)

Sample Carton Image (Image 4)
Packaging label for CINQAIR (reslizumab) injection 100 mg/10 mL (10 mg/mL) concentrate for intravenous infusion. Label indicates single-use vial, sterile solution, must be refrigerated, and diluted prior to administration. Manufactured by Teva Respiratory, LLC. Includes sample not for sale warnings, storage instructions, and barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.